Product image of Migea (Tolfenamic Acid) supplied by GNH India

Migea

Active Ingredient:
Tolfenamic Acid
Origin:
EU

Migea (Tolfenamic Acid)

Tolfenamic acid, the active ingredient in Migea, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats mild to moderate pain and inflammatory conditions such as rheumatoid arthritis, osteoarthritis and dysmenorrhea in adults.

GNH India supplies Migea as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sandoz A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Migea, a non‑steroidal anti‑inflammatory drug, is used for several inflammatory and pain‑related conditions.
  • Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility.
  • Osteoarthritis: alleviates chronic joint discomfort and swelling.
  • Dysmenorrhea: provides analgesic relief of menstrual cramps.

How It Works

  • Tolfenamic acid exerts its effect by non‑selectively inhibiting cyclooxygenase enzymes COX‑1 and COX‑2, which decreases the synthesis of prostaglandins responsible for inflammation, pain, and fever. This reduction in prostaglandin levels leads to diminished inflammatory responses and analgesia in affected tissues.

Side Effects

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

  • Gastrointestinal upset: nausea, dyspepsia, or abdominal pain.
  • Headache: mild to moderate intensity.
  • Dizziness or vertigo.
  • Skin rash or mild pruritus.
  • Elevated liver enzymes (asymptomatic).

Serious or Rare Side Effects

  • Gastrointestinal ulceration or bleeding.
  • Hepatic injury: jaundice or hepatitis.
  • Renal impairment or acute kidney injury.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Anaphylactic or anaphylactoid reactions.
  • Blood dyscrasias: agranulocytosis or thrombocytopenia.

Precautions & Warnings

  • Before prescribing Migea, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.
  • Assess renal function: obtain baseline kidney tests and adjust use in renal impairment.
  • Evaluate hepatic status: monitor liver enzymes, especially in patients with existing liver disease.
  • Check cardiovascular risk: use cautiously in patients with hypertension or heart disease.
  • Avoid in active peptic ulcer disease: consider alternative therapy due to ulcer risk.
  • Store at ambient temperature below 25°C: keep in the original container, protect from moisture.

Avoid Interactions

Tolfenamic acid can interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased bleeding risk.
  • Other NSAIDs or aspirin: additive gastrointestinal toxicity.
  • Corticosteroids: heightened risk of ulceration and bleeding.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: possible reduction in renal function.
  • Diuretics: may enhance nephrotoxic potential.
  • Lithium: NSAIDs can raise lithium serum levels, requiring monitoring.

Frequently Asked Questions

Migea contains tolfenamic acid, an NSAID indicated for mild to moderate pain, inflammatory joint disorders such as rheumatoid arthritis and osteoarthritis, and dysmenorrhea. It helps reduce inflammation and relieve associated discomfort in these conditions.

Tolfenamic acid works by non‑selectively blocking the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for prostaglandin production. Lower prostaglandin levels lead to reduced inflammation, pain, and fever at the site of tissue injury.

The appropriate dose of Migea is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and renal or hepatic function. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of tolfenamic acid in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and only under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Migea (tolfenamic acid) belongs to the same class as ibuprofen, diclofenac and naproxen, sharing a similar mechanism of COX inhibition. Compared with some NSAIDs, tolfenamic acid may have a slightly different gastrointestinal safety profile, but overall efficacy and risk considerations are comparable and must be individualized.

Migea should be stored at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Do not store in a bathroom or near heat sources to maintain product stability.

Migea is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may reduce gastrointestinal discomfort. Patients should swallow the tablet whole and not crush or chew it.

Serious risks include gastrointestinal bleeding or ulceration, severe liver injury, acute kidney damage, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of bleeding, jaundice, severe rash, or sudden loss of kidney function.

Migea is contraindicated in patients with known hypersensitivity to tolfenamic acid or other NSAIDs, active peptic ulcer disease, severe heart failure, and those who have experienced serious adverse reactions to similar drugs. It should also be avoided in patients on certain anticoagulants without careful medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tolfenamic Acid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT